| First Author | Werbajh SE | Year | 1998 |
| Journal | FEBS Lett | Volume | 440 |
| Issue | 3 | Pages | 277-81 |
| PubMed ID | 9872386 | Mgi Jnum | J:52158 |
| Mgi Id | MGI:1328512 | Doi | 10.1016/s0014-5793(98)01473-2 |
| Citation | Werbajh SE, et al. (1998) Downregulation of fibronectin transcription in highly metastatic adenocarcinoma cells. FEBS Lett 440(3):277-81 |
| abstractText | Silencing of fibronectin (FN) expression seems to be one of the key mechanisms underlying metastatic behaviour. An inverse correlation exists between FN expression levels and the metastatic potential of two related murine mammary adenocarcinomas, M3 and MM3. Primary cultures of M3 tumour, which is moderately metastatic to lung (40% incidence), show a conspicuous FN extracellular matrix (ECM) and high levels of FN mRNA, while primary cultures of the highly metastatic MM3 tumour (95% lung incidence) are negative for FN in immunofluorescence and show at least 40-fold lower levels of FN mRNA, only detectable by RT-PCR, with a different pattern of alternatively spliced EDI isoforms compared to M3 cells. We show that the FN promoter sequence is not altered in MM3 cells. Transfection experiments with CAT constructs indicate that silencing occurs at the transcriptional level, involving the 220-bp proximal promoter region. |
